PRODUCT OVERVIEW

Skinlite Cream is a topical medicine used for the treatment of melasma, a skin condition that causes dark patches on the face. It is intended for external use only and should be used under medical supervision for short term, intermittent treatment. Regular use as prescribed, along with proper sun protection, helps improve the appearance of facial melasma.

KEY USES AND BENEFITS

Skinlite Cream is used for the treatment of melasma. It helps reduce excess melanin production and promotes skin cell turnover, allowing dark patches to fade more evenly over time. When used as directed and combined with regular sunscreen use, it helps improve skin tone and the overall appearance of facial pigmentation.

COMPOSITION AND HOW IT WORKS

Skinlite Cream contains Hydroquinone, Mometasone, and Tretinoin. Hydroquinone helps reduce excess melanin production, which lightens dark patches on the skin. Mometasone is a corticosteroid that helps reduce inflammation, redness, and irritation associated with treatment. Tretinoin is a vitamin A derivative that promotes skin cell turnover and helps melanin disperse more evenly. Together, these ingredients help improve the appearance of melasma when used under medical supervision.

DIRECTIONS FOR USE

Skinlite Cream is for external use only. Clean and dry the affected area before application. Apply a thin layer of the cream as directed by your doctor. Wash your hands after applying the cream unless your hands are the area being treated. Avoid contact with the eyes, mouth, and mucous membranes. Do not use more than the recommended amount or continue treatment for longer than advised by your doctor.

SIDE EFFECTS

Common side effects of Skinlite Cream include dryness, redness, stinging sensation, burning, itching, and application site irritation. These effects are usually mild and temporary. Consult your doctor if any side effects persist, worsen, or if you experience severe irritation or worsening of skin symptoms.

SAFETY ADVICE

Use Skinlite Cream only under medical supervision and for short term, intermittent treatment. Avoid direct sun exposure and ultraviolet light during treatment, as they may cause repigmentation of treated areas. Apply sunscreen regularly while using this medicine. The safety of this medicine has not been established during pregnancy or in children below 12 years of age. Breastfeeding women should use this medicine with caution and consult their doctor before use. Stop treatment and seek medical advice if severe irritation, hypersensitivity, or worsening of skin symptoms occurs.